24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publication dates

Stem Cell Industry, December 2014 Market Reports from Top Publishers

You might be interested in: Medical Equipment, Therapeutics, Cancer, more »


 
1-10 of about 200 reports for Stem Cell

NeoStem, Inc. - Product Pipeline Review - 2014

NeoStem, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

... cell therapy for amd and retinitis pigmentosa 30product description 30mechanism of action 30r&d progress 30neostem, inc. - Pipeline analysis 31neostem, inc. - Pipeline products ...

International Stem Cell Corporation

International Stem Cell Corporation

  • $ 55
  • Company report
  • December 2014
  • by Wright Investors' Service

... Equity). Also included for international stem cell corporation are the company description, recent stock performance, profitability analysis, dividend analysis, and key data items (ticker, major industry, sub ...

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2014

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

... To evaluate safety and potential efficacy of rhngf in the treatment of retinitis pigmentosa 123mar 11, 2014: reneuron to receive support from foundation fighting blindness for its retinal stem cell therapy ...

Critical Limb Ischemia - Pipeline Review, H2 2014

Critical Limb Ischemia - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

... Cardiomyopathy and other rare disease indications 120mar 26, 2013: reneuron receives regulatory and ethical approvals to commence clinical trial in uk with stem cell therapy cand for critical limb ...

Degenerative Disc Disease - Pipeline Review, H2 2014

Degenerative Disc Disease - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

... R&d progress 53stem cell therapy for degenerative disc disease - drug profile 54product description 54mechanism of action 54r&d progress 54stem cell therapy for degenerative disc disease ...

Zhongyuan Union Stem Cell Bio-Engineering Corp

Zhongyuan Union Stem Cell Bio-Engineering Corp

  • $ 55
  • Company report
  • November 2014
  • by Wright Investors' Service

... Earnings, price/book, price/sales and 52-week price change) and financial position (long-term debt/equity). Also included for zhongyuan union stem cell bio-engineering corp are the company description, recent ...

BIONET Corp. (Symbol:1784) SWOT Analysis, Strategy, Revenues and Profits

BIONET Corp. (Symbol:1784) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Diagnosis, genesis-24 pre-implantation genetic screening services, down syndrome screening methods, spinal muscular atrophy genetic testing, dental pulp stem cell storage service, and preventive genetic ...

MediPost Co., Ltd. (Symbol:078160) SWOT Analysis, Strategy, Revenues and Profits

MediPost Co., Ltd. (Symbol:078160) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Cord blood derived mesenchymal stem cells (hucb-mscs). The company markets products through brands such as cartistem, neurostem, pneumostem and promostem. It collaborates with sungkyunkwan university ...

Biolife Solutions, Inc. (Symbol:BLFS) SWOT Analysis, Strategy, Revenues and Profits

Biolife Solutions, Inc. (Symbol:BLFS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Cord tissue stem cells, and bloodstor. The company caters to regenerative medicine, biobanking, and drug discovery markets. Biolife solutions is headquartered in bothell, washington, the us ...

GENova Biotherapeutics, Inc. (Symbol:GVBP) SWOT Analysis, Strategy, Revenues and Profits

GENova Biotherapeutics, Inc. (Symbol:GVBP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... The company's stem cell technology is a two-way approach including a method to identify specific biomarkers for breast cancer cells and various methods to destroy these malignancies. Genova is headquartered ...

About 1 400 reports for Stem Cell

Download Unlimited Documents from Trusted Public Sources

Stem Cell Industry in Russia

  • January 2013
    21 pages
  • Stem Cell  

  • Russian Federat  

View report >

Annual Report 2014

January 2014

6 Companies for Stem Cell

Read our Company Profiles

Neostem Inc.

United States

Athersys Inc.

United States

Bioheart Inc.

United States

StemCells Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.